A Step Change in a Single Season

As of October 5, 2026, 161 autochthonous West Nile virus infections had been recorded in mainland France. In 2025, the season running from early May to late November counted only 62. The number of cases has thus nearly tripled, even as the 2026 tally is not yet closed.

Of these 161 people, 133 showed symptoms and 60 developed neurological forms. Five deaths were recorded, mainly among elderly people often suffering from comorbidities. Santé publique France remains cautious about the causal link, as attribution requires an individual medical assessment that takes time.

A Virus Leaving the Mediterranean Arc

Virus circulation long remained concentrated around the Mediterranean rim. This year, seven regions were affected: Provence-Alpes-Côte d'Azur, Occitanie, Île-de-France, Auvergne-Rhône-Alpes, Nouvelle-Aquitaine, Pays de la Loire and Centre-Val de Loire. Thirteen départements were affected for the first time.

The mechanism is simple. Culex mosquitoes become infected by biting an infected bird, then transmit the virus to humans. Each new territory where this chain takes hold exposes a population that had not faced the risk.

Why the Absence of a Preventive Tool Changes the Equation

The infection is most often silent or limited to a flu-like state. About 1% of cases nonetheless progress to severe neurological complications, sometimes fatal, especially in the elderly or immunocompromised. There is no marketed vaccine for humans and no preventive treatment. When cases rise, the response is therefore limited to identifying infections and treating severe forms. The burden then falls on surveillance and on services capable of managing neurological damage.

A European Dynamic

France is not isolated. Through the end of September, nearly 1,800 autochthonous human cases were detected in 16 European countries. Italy counted 721, Greece 420, Spain 131 and France 128 on that date, in an already record year.

What the Figures Do Not Say

Several limitations call for caution. The number of deaths is the same as in 2025, at five, despite a far higher case count, and their attribution remains to be confirmed. The contrast between the estimate of 1% severe complications and the 60 neurological forms among the 161 recorded cases suggests that detection focuses mainly on symptomatic cases. Finally, no data in the file measures hospitalizations or costs: the real pressure on facilities remains to be documented.

A Threat Taking Hold

The established facts outline a clear trend: more cases, more territories affected, and no preventive tool for humans. Nothing supports concluding a rise in lethality or quantifying the hospital burden. West Nile virus is, however, becoming a lasting public health surveillance issue in mainland France.

This article was written with the assistance of artificial intelligence and verified by our editorial team.